title: Are renin-angiotensin-aldosterone system inhibitors lifesaving in chronic kidney disease?
authors.affiliation: British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom; University of Groningen, Department of Cardiology, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: k.damman@umcg.nl.
authors.forename: Kevin
authors.initials: K
authors.lastname: Damman
authors.affiliation: University of Groningen, Department of Clinical Pharmacology, University Medical Center Groningen, Groningen, the Netherlands.
authors.forename: Hiddo J
authors.initials: HJ
authors.lastname: Lambers-Heerspink
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D051436:Renal Insufficiency, Chronic / Q000188:drug therapy* / Q000401:mortality*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors
keywords: CKD; RAAS inhibitors; mortality